Erin Guarnieri
Payments from drug & device makers
Across 95 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$440
- AstraZeneca$246
- Bayer$192
- Mannkind Corporation$169
- Novo Nordisk$168
- Tolmar, Inc.$153
- plus $867 from 20 others
What the payments were for
- Food & beverage$2,235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $440 |
| AstraZeneca | 9 | $246 |
| Bayer | 4 | $192 |
| Mannkind Corporation | 7 | $169 |
| Novo Nordisk | 9 | $168 |
| Tolmar, Inc. | 8 | $153 |
| Pfizer | 5 | $96 |
| Inspire Medical Systems, Inc. | 1 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $91 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Merz North America, Inc. | 1 | $69 |
| Amgen | 2 | $52 |
| Lilly USA, LLC | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Medtronic | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Grifols USA, LLC | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Cequr Corporation | 1 | $17 |
| Biogen | 1 | $15 |
| Abiomed | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$130
How this compares
$2,235 in reported general payments places this provider in the 90th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $688 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $548 |
| Oxycodone Hcl | 47 | $538 |
| Quetiapine Fumarate | 35 | $535 |
| Gabapentin | 42 | $420 |
| Morphine Sulfate ErMorphine Sulfate | 18 | $392 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $301 |
| Omeprazole | 16 | $288 |
| Levothyroxine Sodium | 17 | $235 |
| Rosuvastatin Calcium | 11 | $232 |
| Cyclobenzaprine Hcl | 20 | $210 |
| Atorvastatin Calcium | 14 | $156 |
| Alprazolam | 13 | $135 |
| Sertraline Hcl | 12 | $101 |
| Zolpidem Tartrate | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other family in Upton
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.